As of , CVE-2026-123218 in IBM Aspera Faspex is on CISA's list of exploited vulnerabilities: CISA listed it on . Our patch-first group: Patch now.
CVE-2026-123218
IBM Aspera Faspex: Incorrect Authorization. Exploited, and in our Patch now group.
Our patch-first group
Patch now
- Forensic triage required by CISA
- Listed in the last 14 days
CISA's required action
Apply mitigations in accordance with vendor instructions, ensuring compliance with CISA’s BOD 26-04 Prioritizing Security Updates Based on Risk (see URL in Notes) guidance and CISA’s “Forensics Triage Requirements” (see URL in Notes). Follow applicable BOD 26-04 guidance for cloud services or discontinue use of the product if mitigations are unavailable. Stakeholders are responsible for evaluating each asset's internet exposure and ensuring adherence to BOD 26-04 patching guidelines.
Patch infofixed versions and vendor advice
What to install
Affects IBM Aspera Faspex from 5.0.0 up to and including 5.0.19.
The record's list of affected products names no fixed version.
Vendor advice
Vendor advice: www.ibm.com, from CISA's entry.
- EPSS score
- 0.01Higher than 64% of the CVEs EPSS scores.
EPSS estimates the chance of exploitation activity in the next 30 days.
- Exploited
- Yes CISA listed it on 9 November 2026
- US federal deadline
- 12 November 2026 3 days after CISA listed it. US federal civilian agencies must fix it by then.
- Used in ransomware campaigns
- Not known to CISA
- EPSS when listed
- 0.00 on 9 November 2026 EPSS on the day CISA listed it.
- Public exploit
- None found Neither Metasploit nor Exploit-DB lists one.
Since listing
EPSS since listing
EPSS for CVE-2026-123218 since CISA listed it, on the days its value to 2 decimals changed. EPSS scores by FIRST.
Show the numbers
| From | EPSS |
|---|---|
| 0.00 | |
| 0.01 |
Timeline
What happened when
- The CVE record was published.
- CISA added it to its list of exploited vulnerabilities.
- The US federal deadline to fix it.
CISA's required action
What CISA says to do
Apply mitigations in accordance with vendor instructions, ensuring compliance with CISA’s BOD 26-04 Prioritizing Security Updates Based on Risk (see URL in Notes) guidance and CISA’s “Forensics Triage Requirements” (see URL in Notes). Follow applicable BOD 26-04 guidance for cloud services or discontinue use of the product if mitigations are unavailable. Stakeholders are responsible for evaluating each asset's internet exposure and ensuring adherence to BOD 26-04 patching guidelines.
Agencies must also look for signs that attackers already got in.
Read further: CISA's catalog
The flaw
What the flaw is
IBM Aspera Faspex contains an incorrect authorization vulnerability that could allow an authenticated user to craft a specific message to bypass authorization, causing privilege escalations.
CISA's description
IBM Aspera Faspex 5.0.0 through 5.0.19 could allow an authorized user to craft a specific message to bypass user authorization and gain full administrative privileges.
The CVE record's description, from ibm
- CVE published
- 7 November 2026
- Assigned by
- ibm
- CVSS
- 9.8 Critical (CVSS 3.1, from the CNA)
- CWE-863
- Incorrect Authorization
- CISA SSVC, exploitation
- active
- CISA SSVC, automatable
- yes
- CISA SSVC, technical impact
- total
Same product
Aspera Faspex: other exploited entries
| Vulnerability | Product | Our group | Listed | Deadline | EPSS |
|---|---|---|---|---|---|
| CVE-2022-47986Code Execution | Aspera Faspex | Patch this weekRansomware | Due | 0.99 |
Sources
- CVE records: Copyright © 1999-2026, The MITRE Corporation. CVE is a trademark and the CVE logo is a registered trademark of The MITRE Corporation (source). Licence: CVE Program Terms of Use
- CWE names: Copyright © 2006-2026, The MITRE Corporation. CWE, CWSS, CWRAF, and the CWE logo are trademarks of The MITRE Corporation (source). Licence: CWE Terms of Use
- EPSS scores by FIRST (https://www.first.org/epss/), generated by Empirical Security (source)